STAT August 16, 2023
Sarah Owermohle

A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely, partially upholding a lower court’s decision.

The decision from the three-judge panel of the 5th U.S. Circuit Court of Appeals would effectively block mail-order prescriptions of the pill. However, access will remain unchanged for now, as the Supreme Court issued an emergency order this spring to preserve the status quo while the case goes through the appeals process.

The case is all but assured to head to the highest court, which last year overturned Roe v. Wade. Since the ruling, 14 states have implemented abortion bans and another 11 have imposed limits, some up to six weeks...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies, Patient / Consumer, Provider
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
The Evidence for Gratitude and Health, 2024 Giving Thanks
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
277 million patients' data drives Epic's research findings
Growing gulf in US life expectancy deepened by COVID-19 pandemic

Share This Article